Medallion Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Medallion Wealth Advisors's IBB Position: Q3 2026 in Review
Medallion Wealth Advisors held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 510 shares worth $107K. The position accounts for 0.03% of the portfolio, ranked #335.
Medallion Wealth Advisors first reported a position in IBB in Q4 2024 and has held it in 8 quarters since. 1,030 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Medallion Wealth Advisors held 510 shares of iShares Biotechnology ETF worth $107K as of Q3 2026.
- Medallion Wealth Advisors left its iShares Biotechnology ETF share count unchanged in Q3 2026.
- iShares Biotechnology ETF made up 0.03% of Medallion Wealth Advisors's portfolio in Q3 2026, its #335 holding.
- Medallion Wealth Advisors first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 8 quarters since.
- 1,030 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Medallion Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.